Skip to main content
. 2022 Dec 20;4(5):579–597. doi: 10.1016/j.jaccao.2022.09.004

Figure 5.

Figure 5

General Management Principles of irAEs

The management of immune-related adverse events (irAEs) depends on severity and involves consideration for suspension of therapy, corticosteroids, and/or immunosuppression.59, 60, 61 Management of some organ-specific irAEs may differ from the provided flow chart. CTCAE = Common Terminology Criteria for Adverse Events; ICI = immune checkpoint inhibitor.